1. Armitage JO. Treatment of non-Hodgkin's lymphoma. N Engl J Med 1993;328:1023–1030PMID : 8450856.
2. Fisher RI, Miller TP, Dana BW, Jones SE, Dahlberg S, Coltman CA Jr. Southwest oncology group clinical trials for intermediate and high grade non-Hodgkin's lymphoma. Semin Hematol 1987;24(2 Suppl 1):21–25PMID : 2438778.
3. Carde P, Meerwaldt JH, van Glabbeke M, Somers R, Monconduit M, Thomas J, de Wolf-Peeters C, de Pauw B, Tanguy A, Kluin-Nelemans JC. Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high grade non-Hodgkins lymphoma: the 1980-1985 EORTC trial. Ann Oncol 1991;2:431–435PMID : 1722697.
4. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM, Glick JH, Coltman CA Jr, Miller TP. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993;328:1002–1006PMID : 7680764.
5. Cabanillas F. Experience with salvage regimens at M.D. Anderson Hospital. Ann Oncol 1991;2(Suppl 1):31–32PMID : 1904269.
6. Cabanillas F, Hagemeister FB, Bodey GP, Freireich EJ. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy. Blood 1982;60:693–697PMID : 7104493.
7. Cabanillas F, Hagemeister FB, McLaughlin P, Velasquez WS, Riggs S, Fuller L, Smith T. Results of MIME salvage regimen for recurrent or refractory lymphoma. J Clin Oncol 1987;5:407–412PMID : 3819806.
8. Velasquez WS, Cabanillas F, Salvador P, McLaughlin P, Fridrik M, Tucker S, Jagannath S, Hagemeister FB, Redman JR, Swan F. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP). Blood 1988;71:117–122PMID : 3334893.
9. Wilson WH, Bryant G, Bates S, Fojo A, Wittes RE, Steinberg SM, Kohler DR, Jaffe ES, Herdt J, Cheson BD, Chabner BA. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma. J Clin Oncol 1993;11:1573–1582PMID : 7687667.
10. Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, Colombat P, Goldstone AH, Gorin NC, Flesh M. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high grade non-Hodgkin's lymphoma. N Engl J Med 1987;316:1493–1498PMID : 3295541.
11. Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA, Romaguera J, Rubenstein E, Cabanillas F. ESHAP: an effective chemotherapy regimen in refractory and relapsing lymphoma: a four-year follow-up study. J Clin Oncol 1994;12:1169–1176PMID : 8201379.
12. Ezzat A, Khalifa F, Berry J, Khan B, Raja MA, Abdel-Warith A. ESHAP: an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma. Ann Oncol 1994;5:453–456PMID : 8075052.
13. Wang WS, Chiou TJ, Liu JH, Fan FS, Yen CC, Tung SL, Chen PM. ESHAP as salvage therapy for refractory non-Hodgkin's lymphoma: Taiwan experience. Jpn J Clin Oncol 1999;29:33–37PMID : 10073149.
14. Bergerat JP, Dreawinko B, Corry P, Barlogie B, Ho DH. Synergistic lethal effect of cis-dichlorodiammineplatinum and 1-b-D-arabinosylcytosine. Cancer Res 1981;41:25–30PMID : 7192598.
16. Johnson PW, Sweetenham JW, McCallum P, Norton AJ, Rohartiner AZ, Lister TA. E-SHAP: inadequate treatment for poor-prognosis recurrent lymphoma. Ann Oncol 1993;4:63–67PMID : 8435365.
17. Coiffier B. Treatment of aggressive non-Hodgkin's lymphoma. Semin Oncol 1999;26:12–20PMID : 10561013.
18. Appelbaum RF, Herzig GP, Ziegler JL, Graw RG, Levine AS, Deisseroth AB. Successful engraftment of cryopreserved autologous bone marrow in patients with malignant lymphoma. Blood 1978;52:85–95PMID : 350316.
19. Ho AD, del Valle FD, Ruckle H, Schwammborn J, Schlimok G, Hiddemann W, Meusers P, Thiel E, Dorken B, Hunstein W. Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkins lymphoma. Cancer 1989;64:1388–1392PMID : 2776103.
20. Rodriguez-Monge EJ, Cabanillas F. Long-term follow-up of platinum-based lymphoma salvage regimens: the M.D. Anderson Cancer Center experience. Hematol Oncol Clin North Am 1997;11:937–947PMID : 9336723.
21. Rodriguez MA, Cabanillas FC, Velasquez W, Hagemeister FB, McLaughlin P, Swan F, Romaguera JE. Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP. J Clin Oncol 1995;13:1734–1741PMID : 7602363.
22. Gisselbrecht C, Mounier N. Improving second-line therapy in aggressive non-Hodgkin's lymphoma. Semin Oncol 2004;31(1 Suppl 2):12–16PMID : 15042529.